生物技术
About
生物技术 是本所业务分支，下属于 生命科学.
为生物技术提供领先的知识产权保护
从业50多年来，飞翰曾与多家领先的生物技术公司合作，共同制定和实施成功的知识产权策略，包括为新发明申办专利、在诉讼中执行专利以及就他人提出的侵权指控或产权拥有提供辩护。飞翰曾担任礼来公司(Eli Lilly and Company)的代理人，并在涉及首个由生物技术生产并上市销售的产品—人体胰岛素—的诉讼中取得胜诉。我们提供的咨询或诉讼服务涉及多种技术，例如DNA自动测序、克隆羊多利(Dolly the sheep)、 胎儿染色体异常的无创方法检测、以及抗体平台的设计。
经验
Advised a biotechnology company on patents covering a well-known biologic medicine for treating eye diseases.
Advised a life sciences company in navigating the patent landscape in the DNA sequencing space and preparing to clear the way for its human genomic sequencing technology.
Advised a global pharma company on loss of exclusivity and enforcement strategy in relation to its platelet inhibitor drug.
Finnegan represents BrainCo, a developer of brain-machine interface (BMI) wearables that combine electroencephalography (EEG) signal processing with artificial intelligence (AI) and machine learning (ML) to enable users to control electronic devices using brain signals. The firm works with BrainCo to develop and implement its intellectual property strategy, including drafting and prosecuting utility and design patent applications, in support of the company’s efforts to build a robust patent portfolio covering innovations and designs related to BMI technologies used in toys, smart home appliances, and robotic devices.
Representing Sarepta in defensive patent litigation involving Elevidys®, a one-time gene therapy for the treatment of a neuromuscular disease known as Duchenne muscular dystrophy (DMD) and in parallel offensive inter partes reviews (IPRs).
1:24-cv-00882, D. Del., Judge Andrews
2:23-cv-00094, 2:23-cv-02364, D.N.J., Judges Cecchi, Padin, Wettre
